Targeting Dopaminergic Pathways: Current and Emerging Dopamine Inhibitors in Neurological and Psychiatric Disorders.


Deniz G.

CNS & neurological disorders drug targets, vol.25, no.0, pp.1-13, 2026 (SCI-Expanded, Scopus)